Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nose Neoplasms | 4 | 2006 | 249 | 0.820 |
Why?
|
Central Nervous System Infections | 4 | 2014 | 61 | 0.780 |
Why?
|
Ependymoma | 2 | 2017 | 320 | 0.580 |
Why?
|
Magnetic Resonance Imaging | 30 | 2022 | 36426 | 0.470 |
Why?
|
Intelligence | 1 | 2019 | 924 | 0.470 |
Why?
|
Myelitis | 1 | 2014 | 49 | 0.450 |
Why?
|
Encephalitis | 1 | 2014 | 440 | 0.350 |
Why?
|
Carotid Artery, Internal | 2 | 2003 | 445 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 26 | 2019 | 20569 | 0.330 |
Why?
|
Guanine Nucleotide Exchange Factors | 3 | 2011 | 569 | 0.330 |
Why?
|
Central Nervous System Neoplasms | 1 | 2017 | 916 | 0.320 |
Why?
|
Cerebral Hemorrhage | 1 | 2019 | 2656 | 0.300 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2006 | 242 | 0.280 |
Why?
|
Frontal Sinus | 2 | 2004 | 51 | 0.280 |
Why?
|
Cysts | 3 | 2018 | 681 | 0.270 |
Why?
|
Radiology | 2 | 2019 | 2113 | 0.270 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 147 | 0.270 |
Why?
|
Fasciitis, Necrotizing | 1 | 2006 | 79 | 0.260 |
Why?
|
Spinal Cord | 1 | 2014 | 1819 | 0.260 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2578 | 0.240 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 65 | 0.240 |
Why?
|
Hemangiopericytoma | 1 | 2005 | 71 | 0.240 |
Why?
|
Solvents | 1 | 2005 | 295 | 0.230 |
Why?
|
Odontogenic Cysts | 1 | 2004 | 42 | 0.220 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2004 | 38 | 0.220 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2004 | 53 | 0.220 |
Why?
|
Meningioma | 2 | 2020 | 1218 | 0.220 |
Why?
|
Bell Palsy | 1 | 2003 | 39 | 0.220 |
Why?
|
Mandibular Neoplasms | 1 | 2004 | 130 | 0.210 |
Why?
|
Parotid Diseases | 1 | 2003 | 49 | 0.210 |
Why?
|
Tympanic Membrane | 1 | 2004 | 232 | 0.210 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2003 | 134 | 0.210 |
Why?
|
Pharynx | 1 | 2005 | 432 | 0.200 |
Why?
|
Appetite | 2 | 2014 | 247 | 0.200 |
Why?
|
Cocaine-Related Disorders | 1 | 2005 | 461 | 0.190 |
Why?
|
Neck | 1 | 2006 | 734 | 0.190 |
Why?
|
Oropharynx | 1 | 2002 | 138 | 0.190 |
Why?
|
Plasmacytoma | 1 | 2002 | 171 | 0.190 |
Why?
|
Brain | 12 | 2019 | 27121 | 0.190 |
Why?
|
Hallucinogens | 1 | 2005 | 197 | 0.190 |
Why?
|
Facial Nerve | 1 | 2003 | 277 | 0.190 |
Why?
|
Marijuana Abuse | 1 | 2005 | 411 | 0.190 |
Why?
|
Brain Neoplasms | 6 | 2022 | 9031 | 0.180 |
Why?
|
Carotid Arteries | 1 | 2005 | 941 | 0.180 |
Why?
|
Central Nervous System Diseases | 1 | 2005 | 520 | 0.180 |
Why?
|
Ear, Middle | 1 | 2003 | 339 | 0.180 |
Why?
|
Tinnitus | 1 | 2003 | 196 | 0.180 |
Why?
|
Spinal Diseases | 1 | 2005 | 564 | 0.170 |
Why?
|
Neurofibromatosis 1 | 1 | 2005 | 561 | 0.170 |
Why?
|
Meningeal Neoplasms | 2 | 2020 | 1248 | 0.170 |
Why?
|
Calcinosis | 2 | 2013 | 1469 | 0.170 |
Why?
|
Neuroradiography | 1 | 2019 | 71 | 0.170 |
Why?
|
Cauda Equina | 1 | 2019 | 45 | 0.170 |
Why?
|
Nasal Polyps | 1 | 2005 | 395 | 0.170 |
Why?
|
Chondroma | 1 | 2018 | 53 | 0.160 |
Why?
|
Hemangioma | 1 | 2003 | 727 | 0.150 |
Why?
|
Arnold-Chiari Malformation | 1 | 2020 | 158 | 0.150 |
Why?
|
Granular Cell Tumor | 1 | 2018 | 48 | 0.150 |
Why?
|
Foreign Bodies | 1 | 2002 | 402 | 0.150 |
Why?
|
Spinal Cord Compression | 1 | 2019 | 235 | 0.140 |
Why?
|
Mycoses | 2 | 2014 | 386 | 0.140 |
Why?
|
Intracranial Aneurysm | 2 | 2020 | 1285 | 0.140 |
Why?
|
Neoplasm Invasiveness | 1 | 2005 | 3597 | 0.140 |
Why?
|
Deglutition Disorders | 1 | 2002 | 625 | 0.140 |
Why?
|
Eating | 2 | 2014 | 1539 | 0.130 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2016 | 78 | 0.130 |
Why?
|
Brain Diseases | 1 | 2005 | 1546 | 0.130 |
Why?
|
rho GTP-Binding Proteins | 2 | 2011 | 276 | 0.130 |
Why?
|
Brain Stem Neoplasms | 1 | 2017 | 190 | 0.120 |
Why?
|
Intracranial Hypotension | 1 | 2015 | 42 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4514 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 710 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 1 | 2020 | 819 | 0.120 |
Why?
|
Atrophy | 4 | 2013 | 1633 | 0.120 |
Why?
|
Fibrous Dysplasia, Polyostotic | 2 | 2004 | 39 | 0.110 |
Why?
|
Humans | 60 | 2022 | 761578 | 0.110 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2020 | 801 | 0.110 |
Why?
|
Radiosurgery | 2 | 2020 | 1342 | 0.110 |
Why?
|
Prion Diseases | 1 | 2014 | 100 | 0.110 |
Why?
|
Sodium Chloride | 1 | 2015 | 587 | 0.110 |
Why?
|
Cerebral Arterial Diseases | 1 | 2013 | 82 | 0.100 |
Why?
|
Cerebral Angiography | 3 | 2013 | 1281 | 0.100 |
Why?
|
Spermatozoa | 1 | 2016 | 630 | 0.100 |
Why?
|
rhoA GTP-Binding Protein | 2 | 2011 | 234 | 0.100 |
Why?
|
Forecasting | 2 | 2019 | 2928 | 0.100 |
Why?
|
Hydrocephalus | 1 | 2018 | 764 | 0.090 |
Why?
|
Artifacts | 1 | 2019 | 1911 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 662 | 0.090 |
Why?
|
Glycemic Index | 1 | 2013 | 396 | 0.090 |
Why?
|
Follicular Phase | 1 | 2011 | 143 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 2 | 2013 | 240 | 0.090 |
Why?
|
Clinical Competence | 2 | 2019 | 4793 | 0.090 |
Why?
|
Opioid-Related Disorders | 1 | 2005 | 2164 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 1490 | 0.090 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1496 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1324 | 0.080 |
Why?
|
Female | 31 | 2020 | 392688 | 0.080 |
Why?
|
Embolism | 1 | 2013 | 399 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2922 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6346 | 0.080 |
Why?
|
Middle Aged | 21 | 2020 | 220917 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4420 | 0.080 |
Why?
|
Virus Diseases | 1 | 2014 | 718 | 0.080 |
Why?
|
Cerebral Arteries | 1 | 2011 | 490 | 0.080 |
Why?
|
Gadolinium | 2 | 2022 | 960 | 0.080 |
Why?
|
Protein Structure, Secondary | 2 | 2011 | 1229 | 0.080 |
Why?
|
Corpus Callosum | 1 | 2013 | 751 | 0.080 |
Why?
|
Brain Edema | 1 | 2012 | 604 | 0.070 |
Why?
|
Male | 27 | 2020 | 360841 | 0.070 |
Why?
|
Gait | 1 | 2013 | 814 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3482 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2019 | 14665 | 0.070 |
Why?
|
Pain | 1 | 2002 | 5073 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 1 | 2013 | 1164 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2016 | 3713 | 0.070 |
Why?
|
Leptin | 1 | 2014 | 1597 | 0.070 |
Why?
|
Biochemistry | 1 | 2007 | 114 | 0.070 |
Why?
|
Reward | 1 | 2013 | 971 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2011 | 3792 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2947 | 0.070 |
Why?
|
Biophysics | 1 | 2007 | 380 | 0.070 |
Why?
|
Protein Isoforms | 1 | 2011 | 1699 | 0.070 |
Why?
|
Internship and Residency | 2 | 2019 | 5882 | 0.060 |
Why?
|
Alcohol-Induced Disorders, Nervous System | 1 | 2005 | 13 | 0.060 |
Why?
|
Toluene | 1 | 2005 | 32 | 0.060 |
Why?
|
Dimerization | 1 | 2007 | 891 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2022 | 39107 | 0.060 |
Why?
|
Avitaminosis | 1 | 2005 | 35 | 0.060 |
Why?
|
Narcotics | 1 | 2007 | 336 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2019 | 15633 | 0.060 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2004 | 24 | 0.060 |
Why?
|
Adult | 13 | 2020 | 221200 | 0.060 |
Why?
|
Fasting | 1 | 2011 | 1603 | 0.060 |
Why?
|
raf Kinases | 1 | 2005 | 118 | 0.060 |
Why?
|
Methadone | 1 | 2007 | 321 | 0.060 |
Why?
|
Dura Mater | 2 | 2018 | 290 | 0.060 |
Why?
|
Fibrous Dysplasia, Monostotic | 1 | 2004 | 8 | 0.060 |
Why?
|
Epistaxis | 1 | 2005 | 112 | 0.060 |
Why?
|
Postural Balance | 1 | 2009 | 622 | 0.060 |
Why?
|
Petrous Bone | 1 | 2004 | 85 | 0.060 |
Why?
|
Mucocele | 1 | 2004 | 51 | 0.060 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2011 | 1033 | 0.060 |
Why?
|
Debridement | 1 | 2006 | 493 | 0.060 |
Why?
|
Azacitidine | 1 | 2005 | 336 | 0.050 |
Why?
|
Brain Abscess | 1 | 2004 | 120 | 0.050 |
Why?
|
Empty Sella Syndrome | 1 | 2002 | 14 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 2748 | 0.050 |
Why?
|
Mastoiditis | 1 | 2002 | 37 | 0.050 |
Why?
|
Visual Perception | 1 | 2011 | 1389 | 0.050 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2004 | 178 | 0.050 |
Why?
|
Radiography | 2 | 2005 | 6965 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1125 | 0.050 |
Why?
|
Sampling Studies | 1 | 2004 | 615 | 0.050 |
Why?
|
Parotid Neoplasms | 1 | 2004 | 157 | 0.050 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2002 | 87 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2005 | 1157 | 0.050 |
Why?
|
Sjogren's Syndrome | 1 | 2004 | 238 | 0.050 |
Why?
|
Nasal Mucosa | 1 | 2005 | 416 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3359 | 0.050 |
Why?
|
Encephalocele | 1 | 2002 | 135 | 0.050 |
Why?
|
Pharyngeal Diseases | 1 | 2002 | 134 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2014 | 12973 | 0.050 |
Why?
|
Fistula | 1 | 2002 | 212 | 0.050 |
Why?
|
Neck Injuries | 1 | 2002 | 160 | 0.050 |
Why?
|
Protein Binding | 3 | 2011 | 9353 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1405 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1833 | 0.040 |
Why?
|
Bone Diseases | 1 | 2004 | 418 | 0.040 |
Why?
|
Nasal Cavity | 1 | 2002 | 304 | 0.040 |
Why?
|
Risk Assessment | 4 | 2005 | 23996 | 0.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2002 | 324 | 0.040 |
Why?
|
Radiographic Image Enhancement | 1 | 2004 | 876 | 0.040 |
Why?
|
Brain Mapping | 3 | 2013 | 6635 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2002 | 1045 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2020 | 5247 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6391 | 0.040 |
Why?
|
Intubation, Intratracheal | 1 | 2006 | 1333 | 0.040 |
Why?
|
Phantom Limb | 1 | 2000 | 98 | 0.040 |
Why?
|
Cerebral Aqueduct | 1 | 2018 | 40 | 0.040 |
Why?
|
Craniotomy | 2 | 2020 | 741 | 0.040 |
Why?
|
Cysticercosis | 1 | 1997 | 35 | 0.040 |
Why?
|
Rhinitis | 1 | 2005 | 747 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1626 | 0.040 |
Why?
|
Aged | 9 | 2020 | 169308 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2009 | 2297 | 0.030 |
Why?
|
HIV Infections | 1 | 2003 | 17352 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3267 | 0.030 |
Why?
|
Sinusitis | 1 | 2005 | 991 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2013 | 1835 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13446 | 0.030 |
Why?
|
Blotting, Western | 3 | 2011 | 5036 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2020 | 607 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2872 | 0.030 |
Why?
|
Injections, Spinal | 1 | 2015 | 318 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 80646 | 0.030 |
Why?
|
Sperm Motility | 1 | 2016 | 266 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17635 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 909 | 0.030 |
Why?
|
Hemangioma, Cavernous | 1 | 1994 | 107 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2020 | 2898 | 0.030 |
Why?
|
Adolescent | 4 | 2014 | 88323 | 0.030 |
Why?
|
Signal Transduction | 2 | 2007 | 23447 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2005 | 3677 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4317 | 0.030 |
Why?
|
Pregnancy | 3 | 2020 | 29876 | 0.030 |
Why?
|
Contrast Media | 2 | 2019 | 5307 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 940 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1166 | 0.030 |
Why?
|
Ultrasonography | 1 | 2005 | 5971 | 0.020 |
Why?
|
Glycolysis | 1 | 2016 | 835 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2011 | 123 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2013 | 275 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2014 | 64684 | 0.020 |
Why?
|
Hunger | 1 | 2013 | 206 | 0.020 |
Why?
|
Postprandial Period | 1 | 2013 | 315 | 0.020 |
Why?
|
Isoenzymes | 1 | 2016 | 1687 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 1990 | 0.020 |
Why?
|
Deep Brain Stimulation | 1 | 2019 | 832 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12947 | 0.020 |
Why?
|
DNA Methylation | 1 | 2005 | 4399 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2005 | 1991 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2011 | 344 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2011 | 335 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2011 | 646 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2005 | 11120 | 0.020 |
Why?
|
Food | 1 | 2014 | 774 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 1989 | 0.020 |
Why?
|
Hypothalamus | 1 | 2014 | 999 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13642 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1638 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2014 | 751 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9491 | 0.020 |
Why?
|
Software | 1 | 2022 | 4434 | 0.020 |
Why?
|
Developing Countries | 1 | 2001 | 2885 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 2072 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58983 | 0.020 |
Why?
|
Stroke | 1 | 2011 | 9758 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2014 | 1987 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2006 | 7406 | 0.020 |
Why?
|
Sensation Disorders | 1 | 2009 | 160 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2009 | 172 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12725 | 0.020 |
Why?
|
Agar | 1 | 2005 | 51 | 0.020 |
Why?
|
Incidence | 1 | 2004 | 21355 | 0.020 |
Why?
|
Butadienes | 1 | 2005 | 107 | 0.020 |
Why?
|
Methanol | 1 | 2005 | 92 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2009 | 857 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20099 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 2004 | 60 | 0.010 |
Why?
|
Cell Line | 2 | 2011 | 15601 | 0.010 |
Why?
|
Estradiol | 1 | 2011 | 1937 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2005 | 670 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2005 | 1545 | 0.010 |
Why?
|
Parotid Gland | 1 | 2004 | 175 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22176 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2400 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 532 | 0.010 |
Why?
|
Flavonoids | 1 | 2005 | 445 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15843 | 0.010 |
Why?
|
3T3 Cells | 1 | 2003 | 1085 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9610 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2003 | 685 | 0.010 |
Why?
|
Ovary | 1 | 2005 | 959 | 0.010 |
Why?
|
Amputation Stumps | 1 | 2000 | 38 | 0.010 |
Why?
|
Nitriles | 1 | 2005 | 971 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1136 | 0.010 |
Why?
|
Health Planning | 1 | 2001 | 230 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12059 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2425 | 0.010 |
Why?
|
Ethanol | 1 | 2005 | 1324 | 0.010 |
Why?
|
Mexico | 1 | 2001 | 764 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4063 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2000 | 517 | 0.010 |
Why?
|
Cerebral Ventriculography | 1 | 1997 | 44 | 0.010 |
Why?
|
Mice | 3 | 2016 | 81539 | 0.010 |
Why?
|
Spinal Canal | 1 | 1997 | 41 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2919 | 0.010 |
Why?
|
Subarachnoid Space | 1 | 1997 | 80 | 0.010 |
Why?
|
Equipment Design | 1 | 2005 | 3511 | 0.010 |
Why?
|
Young Adult | 2 | 2014 | 59254 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3597 | 0.010 |
Why?
|
HIV-1 | 1 | 2014 | 6863 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2526 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4125 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3810 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6075 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2005 | 2865 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2005 | 3396 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2005 | 2827 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2725 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1997 | 542 | 0.010 |
Why?
|
Leg | 1 | 2000 | 1088 | 0.010 |
Why?
|
Fibroblasts | 1 | 2005 | 4142 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2003 | 4111 | 0.010 |
Why?
|
Alleles | 1 | 2005 | 6864 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74212 | 0.010 |
Why?
|
Cell Membrane | 1 | 2003 | 3687 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2001 | 1403 | 0.010 |
Why?
|
Animals | 3 | 2016 | 168475 | 0.010 |
Why?
|
Models, Molecular | 1 | 2003 | 5439 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9281 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5672 | 0.010 |
Why?
|
Occipital Lobe | 1 | 1994 | 374 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26127 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2000 | 1436 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12794 | 0.010 |
Why?
|
Child | 1 | 2018 | 80157 | 0.010 |
Why?
|
Rats | 1 | 2005 | 23741 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16990 | 0.000 |
Why?
|
Prospective Studies | 1 | 2013 | 54423 | 0.000 |
Why?
|
Infant | 1 | 2007 | 36193 | 0.000 |
Why?
|
Time Factors | 1 | 2003 | 39970 | 0.000 |
Why?
|
Mutation | 1 | 2005 | 30054 | 0.000 |
Why?
|